These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19231614)

  • 1. Eltrombopag in chronic idiopathic thrombocytopenic purpura.
    Panzer S; Pabinger I
    Lancet; 2009 Feb; 373(9664):607-8. PubMed ID: 19231614
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of eltrombopag on platelet counts and bleeding during treatment of chronic idiopathic thrombocytopenic purpura: a randomised, double-blind, placebo-controlled trial.
    Bussel JB; Provan D; Shamsi T; Cheng G; Psaila B; Kovaleva L; Salama A; Jenkins JM; Roychowdhury D; Mayer B; Stone N; Arning M
    Lancet; 2009 Feb; 373(9664):641-8. PubMed ID: 19231632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eltrombopag increases thrombocyte count and reduces the bleeding risk].
    Med Monatsschr Pharm; 2007 Oct; 30(10):390-1. PubMed ID: 17966290
    [No Abstract]   [Full Text] [Related]  

  • 4. Sustaining platelet counts in chronic ITP.
    Nurden AT
    Lancet; 2011 Jan; 377(9763):358-60. PubMed ID: 20739056
    [No Abstract]   [Full Text] [Related]  

  • 5. Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.
    Bussel JB; Cheng G; Saleh MN; Psaila B; Kovaleva L; Meddeb B; Kloczko J; Hassani H; Mayer B; Stone NL; Arning M; Provan D; Jenkins JM
    N Engl J Med; 2007 Nov; 357(22):2237-47. PubMed ID: 18046028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations.
    Cook L; Cooper N
    Drug Des Devel Ther; 2010 Jul; 4():139-45. PubMed ID: 20689640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe cutaneous toxicity related to Eltrombopag.
    Meyer SC; Rovó A; Tsakiris DA; Scherer K; Tichelli A; Holbro A
    Br J Haematol; 2013 Feb; 160(3):412-4. PubMed ID: 23151239
    [No Abstract]   [Full Text] [Related]  

  • 8. Eltrombopag for the treatment of chronic immune (idiopathic) thrombocytopenic purpura.
    Dmytrijuk A; Robie-Suh K; Rieves D; Pazdur R
    Oncology (Williston Park); 2009 Nov; 23(13):1171-7. PubMed ID: 20043468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): a randomised, multicentre, placebo-controlled trial.
    Grainger JD; Locatelli F; Chotsampancharoen T; Donyush E; Pongtanakul B; Komvilaisak P; Sosothikul D; Drelichman G; Sirachainan N; Holzhauer S; Lebedev V; Lemons R; Pospisilova D; Ramenghi U; Bussel JB; Bakshi KK; Iyengar M; Chan GW; Chagin KD; Theodore D; Marcello LM; Bailey CK
    Lancet; 2015 Oct; 386(10004):1649-58. PubMed ID: 26231455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia: Meta-Analysis of Randomized Controlled Trials.
    Elgebaly AS; Ashal GE; Elfil M; Menshawy A
    Clin Appl Thromb Hemost; 2017 Nov; 23(8):928-937. PubMed ID: 27572890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two new drugs for chronic ITP.
    Med Lett Drugs Ther; 2009 Feb; 51(1305):10-1. PubMed ID: 19197233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eltrombopag: A Review in Paediatric Chronic Immune Thrombocytopenia.
    Burness CB; Keating GM; Garnock-Jones KP
    Drugs; 2016 May; 76(8):869-78. PubMed ID: 27151255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac and pulmonary thrombosis during multidrug treatment in an idiopathic thrombocytopenic purpura patient.
    Andic N; Gunduz E; Akay OM; Şahin D; Teke HÜ
    Platelets; 2014; 25(1):69-70. PubMed ID: 23320868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag.
    Tarantino MD; Fogarty PF; Shah P; Brainsky A
    Platelets; 2015; 26(1):93-6. PubMed ID: 24433306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on eltrombopag for ITP.
    Bussel JB
    Oncology (Williston Park); 2009 Nov; 23(13):1177-8. PubMed ID: 20043469
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapy induced iron deficiency in children treated with eltrombopag for immune thrombocytopenia.
    Lambert MP; Witmer CM; Kwiatkowski JL
    Am J Hematol; 2017 Jun; 92(6):E88-E91. PubMed ID: 28240793
    [No Abstract]   [Full Text] [Related]  

  • 17. Eltrombopag--an oral thrombopoietin agonist.
    Sharma V; Randhawa H; Sharma A; Aggarwal S
    Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):743-6. PubMed ID: 22913204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eltrombopag. Idiopathic thrombocytopenic purpura after treatment failure: romiplostim is a better option.
    Prescrire Int; 2010 Feb; 19(105):15. PubMed ID: 20455333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eltrombopag for use in children with immune thrombocytopenia.
    Kim TO; Despotovic J; Lambert MP
    Blood Adv; 2018 Feb; 2(4):454-461. PubMed ID: 29487060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eltrombopag in thrombocytopenia.
    Zimmer J; Hentges F; Andrès E
    N Engl J Med; 2008 Mar; 358(10):1072; author reply 1072-3. PubMed ID: 18326076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.